Eiffage (FR:FGR) has released an update.
Eiffage, in partnership with Fouchard and Sner, has secured a €72 million contract to expand and renovate the Henri Becquerel cancer treatment center in Rouen, France. Eiffage’s share of the project, which aims to enhance patient experience with sustainable and energy-efficient designs, is valued at €50 million. Construction has commenced with completion expected by 2026, ensuring continuous patient care during the process.
For further insights into FR:FGR stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
